Brookfield Corporation Bought Back: A Bottom Signal for Alternatives?
Brookfield Corporation just bought back a substantial amount of its own stock. The move raises questions about whethe...
Articles — Page 866
Cheesecake Factory Director Sold: A Deep Dive Into the Trade
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
SpaceX Finally Going Public: A $1,000 Investment Guide
SpaceX finally going public would rewrite who can own a piece of the rocket company. This guide breaks down the IPO b...
Ukraine Targets Petersburg After Talks Refusal Hits Markets
Ukraine intensified pressure on St. Petersburg with a drone barrage as Putin rejected Kyiv's call for talks. The stri...
Marvell Technology, Flex Join S&P 500 This Month Soon
Two tech names are set to enter the S&P 500 as part of the latest quarterly rebalance, replacing Pool Corp. and The C...
Oil’s $200 After Biggest Shock Defies Forecasts, Again
Three months after the Hormuz disruption, oil prices remain subdued. Record U.S. exports, a slowdown in Chinese deman...
Luke Bryan Says ‘Fish—What It Means for Money and AI
A country star’s lighthearted single sparks a conversation about AI, creativity, and the real-world finance behind mu...
Uber Driver Woman Waiting: A Real-Life Shield Against Scams
When a 90-something woman faced a bank impostor at her doorstep, an observant Uber driver intervened. This article br...
Older Americans Thought They Were Dating Real Women Online
Romance scams targeting seniors are rising, and AI-driven video tools are making deceptions harder to spot. This arti...
Ryan Specialty's Bought 6,300: What It Signals Investors
When a CFO buys a sizable block of shares, it can hint at confidence in the company’s future. This article breaks dow...
Stock Market Verge Doing: What It Could Mean for Investors
The stock market is flirting with a milestone not seen in 155 years. This article explains what a stock market verge ...
Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...